Tokyo, Japan

Noriyoshi Inukai

This inventor holds 4 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1977-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyoshi Inukai. Retrieved from https://idiyas.com/inventor/noriyoshi-inukai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Tokyo, JP (1981)

Company Filing History:


Years Active: 1977-1981

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Noriyoshi Inukai: Innovator in Prostaglandin Derivatives

Introduction

Noriyoshi Inukai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. With a total of four patents to his name, Inukai's work has had a notable impact on medical science.

Latest Patents

Inukai's latest patents include the invention of 20-alkoxy-16-alkyl-prostadienoic acid derivatives. These compounds exhibit excellent pharmacological effects as prostaglandin E2 and prostaglandin F2α. Another significant patent involves novel 3,15-dilower alkyl PGE2 derivatives, which demonstrate antigastric ulcer activity without undesirable side effects to intestinal organs.

Career Highlights

Inukai is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing research and development in his field. His innovative work has contributed to the understanding and application of prostaglandins in therapeutic settings.

Collaborations

Inukai has collaborated with notable coworkers, including Masuo Murakami and Hidenori Iwamoto. Their combined expertise has fostered advancements in pharmaceutical research and development.

Conclusion

Noriyoshi Inukai's contributions to the field of prostaglandin derivatives highlight his role as a key innovator in pharmaceuticals. His patents reflect a commitment to improving medical treatments and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…